IRIS Institutional Research Information System - OPENBS Open Archive UniBS

NIBBIO, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.954
AS - Asia 1.845
EU - Europa 1.290
SA - Sud America 489
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.632
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.857
SG - Singapore 779
IT - Italia 492
CN - Cina 455
BR - Brasile 414
HK - Hong Kong 211
DE - Germania 194
VN - Vietnam 153
FR - Francia 96
FI - Finlandia 94
GB - Regno Unito 87
RU - Federazione Russa 71
TR - Turchia 63
CA - Canada 49
UA - Ucraina 46
IN - India 38
CZ - Repubblica Ceca 33
MX - Messico 33
PL - Polonia 30
BD - Bangladesh 26
NL - Olanda 26
AR - Argentina 23
AT - Austria 23
IE - Irlanda 21
SE - Svezia 21
ZA - Sudafrica 21
IQ - Iraq 18
JP - Giappone 18
EC - Ecuador 14
ID - Indonesia 14
PY - Paraguay 13
ES - Italia 10
PK - Pakistan 10
SA - Arabia Saudita 9
AL - Albania 8
UZ - Uzbekistan 8
CO - Colombia 7
LT - Lituania 7
MA - Marocco 7
NP - Nepal 6
EG - Egitto 5
PE - Perù 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
ET - Etiopia 4
IL - Israele 4
PA - Panama 4
VE - Venezuela 4
AO - Angola 3
CL - Cile 3
DZ - Algeria 3
KE - Kenya 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PH - Filippine 3
PS - Palestinian Territory 3
RO - Romania 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
NO - Norvegia 2
OM - Oman 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DM - Dominica 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
IM - Isola di Man 1
JM - Giamaica 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
NI - Nicaragua 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 5.632
Salva come PNG Salva come JPEG
Città #
Singapore 404
Ashburn 267
Hong Kong 211
San Jose 167
New York 109
Beijing 104
The Dalles 102
Milan 101
Munich 96
Los Angeles 86
Brescia 70
Helsinki 70
Lauterbourg 60
Fairfield 57
Chandler 55
Boardman 52
Ho Chi Minh City 49
Istanbul 49
São Paulo 40
Chicago 38
Princeton 34
Hanoi 30
Moscow 30
Council Bluffs 29
Redondo Beach 29
Dallas 27
Seattle 27
Warsaw 27
Woodbridge 27
Cambridge 26
Shanghai 26
Jacksonville 25
Orem 24
San Francisco 24
Wilmington 24
Brno 23
Frankfurt am Main 23
Houston 22
Buffalo 21
Dublin 21
London 21
Santa Clara 21
Romola 19
Turku 18
Des Moines 15
Düsseldorf 15
Ann Arbor 14
Nuremberg 14
Palazzolo sull'Oglio 14
Stockholm 14
Tokyo 14
Amsterdam 13
Brooklyn 13
Montreal 13
Toronto 13
Mexico City 12
Turin 12
Denver 11
Haiphong 11
Manchester 11
Atlanta 10
Belo Horizonte 10
Johannesburg 10
Porto Alegre 10
Ankara 9
Guangzhou 9
Olomouc 9
Rome 9
Changsha 8
Dearborn 8
Nanjing 8
Naples 8
New Delhi 8
Paris 8
Phoenix 8
Tashkent 8
Campinas 7
Charlotte 7
Jakarta 7
Poplar 7
Rio de Janeiro 7
San Diego 7
Asunción 6
Bergamo 6
Curitiba 6
Guayaquil 6
Jinan 6
Lappeenranta 6
Querétaro 6
Venice 6
Verona 6
Vienna 6
Brasília 5
Chennai 5
Da Nang 5
Elk Grove Village 5
Hangzhou 5
Manaus 5
Mumbai 5
Neumarkt 5
Totale 3.276
Salva come PNG Salva come JPEG
Nome #
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 192
Autistic symptoms predict social cognitive performance in patients with schizophrenia 166
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics 157
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia: A Systematic Review and Meta-analysis of Randomized Clinical Trials 138
Impact of Physical Exercise Alone or in Combination with Cognitive Remediation on Cognitive Functions in People with Schizophrenia: A Qualitative Critical Review 131
Adult ADHD and sleep disorders: Prevalence, severity and predictors of sleep disorders in a sample of Italian psychiatric outpatients 129
Evidence-Based Integrated Intervention in Patients with Schizophrenia: A Pilot Study of Feasibility and Effectiveness in a Real-World Rehabilitation Setting 126
The Elephant in the Room: A Cross-Sectional Study on the Stressful Psychological Effects of the COVID-19 Pandemic in Mental Healthcare Workers 124
Acceptability of cognitive remediation for schizophrenia: A systematic review and meta-analysis of randomized controlled trials 123
Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indices 115
Cognitive and clinical characteristics of offenders and non-offenders diagnosed with schizophrenia spectrum disorders: results of the Recoviwel observational study 115
Current Evidence and Theories in Understanding the Relationship between Cognition and Depression in Childhood and Adolescence: A Narrative Review 115
Social Cognition in a Research Domain Criteria Perspective: A Bridge Between Schizophrenia and Autism Spectra Disorders 114
Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 113
Autistic Symptoms and Social Cognition Predict Real-World Outcomes in Patients With Schizophrenia 111
Efficacy and tolerability of Brain Stimulation interventions in Borderline Personality Disorder: state of the art and future perspectives – A systematic review 108
Application of cognitive remediation in the world: new experiences from two schizophrenia rehabilitation centers in Togo and Benin 103
Paliperidone extended-release in the short- and long-term treatment of schizophrenia 103
Life engagement in people living with schizophrenia: predictors and correlates of patient life engagement in a large sample of people living in the community 97
Effects of bilateral, bipolar-nonbalanced, frontal transcranial Direct Current Stimulation (tDCS) on negative symptoms and neurocognition in a sample of patients living with schizophrenia: Results of a randomized double-blind sham-controlled trial 97
Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study 92
Autistic symptoms in people with schizophrenia: Neurocognitive, socio-cognitive, clinical and real-world functional characteristics of individuals without autistic features 92
The economic burden of schizophrenia spectrum disorders: clinical and functional correlates and predictors of direct costs. A retrospective longitudinal study 91
Psychological impact of Covid-19 pandemic in mental healthcare workers: a cross-sectional study in an Italian Department of Mental Health 90
Assessment and correlates of autistic symptoms in Schizophrenia Spectrum Disorders measured with the PANSS Autism Severity Score: A systematic review 90
Autistic symptoms in unaffected first-degree relatives of people with schizophrenia: results from the Italian Network for Research on Psychoses multicenter study 90
The role of pharmacogenetics in the treatment of major depressive disorder: a critical review 89
Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features 88
Schizophrenia during the COVID-19 pandemic 86
Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting 83
The Relationship between Cognitive Impairment and Violent Behavior in People Living with Schizophrenia Spectrum Disorders: A Critical Review and Treatment Considerations 83
European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia 81
Implementation of cognitive rehabilitation interventions for schizophrenia in low-income countries: An experience from Togo and Benin 79
Treatment of Cognitive Impairment Associated with Schizophrenia Spectrum Disorders: New Evidence, Challenges, and Future Perspectives 79
Shared and distinct abnormalities in sleep-wake patterns and their relationship with the negative symptoms of Schizophrenia Spectrum Disorder patients 79
Improving depressive symptoms in patients with schizophrenia using bilateral bipolar-nonbalanced prefrontal tDCS: Results from a double-blind sham-controlled trial 78
Conceptualization and characterization of "primary" and "secondary" cognitive impairment in schizophrenia 77
Blood homocysteine concentration and mood disorders with mixed features among patients with alcohol use disorder 76
Is It Possible to Combine Non-Invasive Brain Stimulation and Evidence-Based Psychosocial Interventions in Schizophrenia? A Critical Review 74
Paliperidone palmitate in short- and long-term treatment of schizophrenia 74
Well-Being and Mental Health: Where Do We Stand After COVID-19 Pandemic? 73
What impact can brain stimulation interventions have on borderline personality disorder? 73
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 73
Verso la medicina di precisione in psichiatria: validazione clinica di un approccio farmacogenomico combinato nel trattamento del Disturbo Depressivo Maggiore 71
Personality traits and disorders among adult ADHD Patients: Is borderline personality disorder as common as we expect? 69
Patient-reported outcomes in the clinical management of depression: current status and future directions 69
Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses 67
Efficacy of Functional Remediation on Cognitive and Psychosocial Functioning in Patients with Bipolar Disorder: Study Protocol for a Randomized Controlled Study 67
Predictors of psychosocial functioning in people diagnosed with schizophrenia spectrum disorders that committed violent offences and in those that did not: Results of the Recoviwel study 65
Socio-demographic and clinical characteristics of SARS-CoV-2-positive psychiatric in-patients: A case-control study in the psychiatric wards of a Great Metropolitan Hospital in Milan 64
Non-pharmacological interventions to improve cognitive impairment and psychosocial functioning in schizophrenia: a critical review 62
Editorial: Case reports in schizophrenia and psychotic disorders 57
Evidence-based psychosocial interventions in schizophrenia: A critical review 56
The role of pharmacogenetics in the treatment of major depressive disorder: a critical review 55
Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis 53
Editorial: Methods and applications in psychopathology: new methods and trends for the understanding of neuropsychiatric disorders 52
Effectiveness and Safety of Bright Light Therapy in Oncological Patients: A Systematic Review 52
Gender Differences in Anxiety and Depression before and after Alcohol Detoxification: Anxiety and Depression as Gender-Related Predictors of Relapse 51
Insulin-resistance as a modifiable pathway to cognitive dysfunction in schizophrenia: A systematic review 49
Pharmacological Treatment of Cognitive Impairment Associated With Schizophrenia: State of the Art and Future Perspectives 48
Editorial: Case reports in Schizophrenia and psychotic disorders: 2023 45
MCMI-III Personality Disorders, Traits, and Profiles in Adult ADHD Outpatients 45
Editorial: Cognitive and mental health improvement under- and post-COVID-19, volume III 42
Treatment of Comorbid Adult Attention-deficit/Hyperactivity Disorder and Generalized Anxiety Disorder: 2 Case Reports 40
Reply to: “Letter to the Editor: Cocaine use and cocaine use disorder - Revisiting epidemiology and clinical impact” 39
The interplay between childhood trauma, hopelessness, depressive symptoms, and mental pain in a large sample of patients with severe mental disorders: A network analysis 38
Editorial: Cognitive and mental health improvement under- and post-COVID-19 36
Does pharmacogenetic testing optimise antidepressant effectiveness in major depressive disorder? Data from a double blind randomized controlled trial in a real-world setting 30
Longitudinal impact of CYP2D6 and CYP2C19 metabolizer status on antidepressant response: The role of Pharmacogenetic mismatch 16
Mild motor signs in major depressive disorder: prevalence and clinical profile 7
Totale 5.712
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.592
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 19 15 23
2021/2022131 7 19 8 7 5 6 4 10 7 15 6 37
2022/2023236 21 2 0 13 14 46 20 35 42 7 21 15
2023/2024559 21 15 50 41 32 87 25 12 71 28 4 173
2024/20251.424 26 29 39 165 147 110 129 70 193 134 216 166
2025/20263.067 338 396 252 528 343 229 410 163 203 205 0 0
Totale 5.712